Healthcare ETFs: XLV Offers Low Fees and Solid Returns
The article explores how portfolio concentration and stock count differentiate healthcare ETFs, affecting risk and diversification. It highlights XLV as a low-fee option with solid returns, while comparing it to other funds like IYH and VHT.
According to a report from Motley Fool, healthcare sector ETFs are gaining attention for their low-cost exposure to a defensive industry. Among them, the Health Care Select Sector SPDR Fund (XLV) stands out for its low expense ratio and strong performance.
Details
XLV charges an annual expense ratio of just 0.12%, making it one of the cheapest healthcare ETFs. The fund holds 65 stocks, with heavy concentration in top companies such as Eli Lilly (LLY), Johnson & Johnson (JNJ), and AbbVie (ABBV). This concentration provides exposure to industry leaders but also increases single-stock risk.
Context
Other healthcare ETFs differ in stock count and concentration. For example, the iShares U.S. Healthcare ETF (IYH) holds 120 stocks with a 0.40% expense ratio, offering broader diversification. The Vanguard Health Care ETF (VHT) holds over 400 stocks, reducing individual stock risk but with a 0.10% expense ratio.
What It Means for Investors
Investors should weigh cost versus diversification. XLV is ideal for those seeking low fees and concentrated exposure to mega-cap healthcare stocks. Funds like IYH or VHT suit investors wanting broader diversification at a slightly higher cost. Risk tolerance should guide the choice.
Frequently Asked Questions
Found this useful? Share it